TBL1XR1 and acute promyelocytic leukemia: While the combination of ATRA/ATO with chemotherapy may represent a viable initial approach for TBL1XR1-RARB-positive APL, the observed high relapse rate underscores the potential necessity of hematopoietic stem cell transplantation as a curative intervention for this variant form of APL.